296 related articles for article (PubMed ID: 25345732)
1. Lithium and GSK-3β promoter gene variants influence cortical gray matter volumes in bipolar disorder.
Benedetti F; Poletti S; Radaelli D; Locatelli C; Pirovano A; Lorenzi C; Vai B; Bollettini I; Falini A; Smeraldi E; Colombo C
Psychopharmacology (Berl); 2015 Apr; 232(7):1325-36. PubMed ID: 25345732
[TBL] [Abstract][Full Text] [Related]
2. Lithium and GSK3-β promoter gene variants influence white matter microstructure in bipolar disorder.
Benedetti F; Bollettini I; Barberi I; Radaelli D; Poletti S; Locatelli C; Pirovano A; Lorenzi C; Falini A; Colombo C; Smeraldi E
Neuropsychopharmacology; 2013 Jan; 38(2):313-27. PubMed ID: 22990942
[TBL] [Abstract][Full Text] [Related]
3. Glycogen synthase kinase 3β gene polymorphisms may be associated with bipolar I disorder and the therapeutic response to lithium.
Lin YF; Huang MC; Liu HC
J Affect Disord; 2013 May; 147(1-3):401-6. PubMed ID: 23021822
[TBL] [Abstract][Full Text] [Related]
4. Opposite effects of suicidality and lithium on gray matter volumes in bipolar depression.
Benedetti F; Radaelli D; Poletti S; Locatelli C; Falini A; Colombo C; Smeraldi E
J Affect Disord; 2011 Dec; 135(1-3):139-47. PubMed ID: 21807414
[TBL] [Abstract][Full Text] [Related]
5. Brain-derived Neurotrophic Factor (BDNF) and gray matter volume in bipolar disorder.
Poletti S; Aggio V; Hoogenboezem TA; Ambrée O; de Wit H; Wijkhuijs AJ; Locatelli C; Colombo C; Arolt V; Drexhage HA; Benedetti F
Eur Psychiatry; 2017 Feb; 40():33-37. PubMed ID: 27837670
[TBL] [Abstract][Full Text] [Related]
6. Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder.
Dandekar MP; Valvassori SS; Dal-Pont GC; Quevedo J
Curr Drug Metab; 2018; 19(8):663-673. PubMed ID: 29283064
[TBL] [Abstract][Full Text] [Related]
7. Glycogen synthase kinase-3β activity and cognitive functioning in patients with bipolar I disorder.
Munkholm K; Miskowiak KW; Jacoby AS; Vinberg M; Leme Talib L; Gattaz WF; Kessing LV
Eur Neuropsychopharmacol; 2018 Mar; 28(3):361-368. PubMed ID: 29433844
[TBL] [Abstract][Full Text] [Related]
8. [Association between lithium sensitivity and GSK3beta gene polymorphisms in bipolar disorder].
Numajiri M; Aoki J; Iwahashi K; Fukamauchi F; Enomoto M; Yoshihara E; Murayama O; Nishizawa D; Ikeda K; Ishigooka J
Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Jun; 32(3):161-3. PubMed ID: 22834106
[TBL] [Abstract][Full Text] [Related]
9. Association study of the glycogen synthase kinase-3beta gene polymorphism with prophylactic lithium response in bipolar patients.
Szczepankiewicz A; Rybakowski JK; Suwalska A; Skibinska M; Leszczynska-Rodziewicz A; Dmitrzak-Weglarz M; Czerski PM; Hauser J
World J Biol Psychiatry; 2006; 7(3):158-61. PubMed ID: 16861141
[TBL] [Abstract][Full Text] [Related]
10. A Homer 1 gene variant influences brain structure and function, lithium effects on white matter, and antidepressant response in bipolar disorder: A multimodal genetic imaging study.
Benedetti F; Poletti S; Locatelli C; Mazza E; Lorenzi C; Vitali A; Riberto M; Brioschi S; Vai B; Bollettini I; Melloni E; Aggio V; Falini A; De Bartolomeis A; Colombo C
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():88-95. PubMed ID: 29079138
[TBL] [Abstract][Full Text] [Related]
11. Lithium treatment impacts nucleus accumbens shape in bipolar disorder.
Vecchio D; Piras F; Piras F; Banaj N; Janiri D; Simonetti A; Sani G; Spalletta G
Neuroimage Clin; 2020; 25():102167. PubMed ID: 31972398
[TBL] [Abstract][Full Text] [Related]
12. Association of a GSK-3β polymorphism with brain resting-state function in amnestic-type mild cognitive impairment.
Bai F; Shi Y; Yuan Y; Yue C; Zhuang L; Xu X; Liu X; Zhang Z
J Alzheimers Dis; 2012; 32(2):387-96. PubMed ID: 22785398
[TBL] [Abstract][Full Text] [Related]
13. Gene-gene interaction of glycogen synthase kinase 3-β and serotonin transporter on human antidepressant response to sleep deprivation.
Benedetti F; Dallaspezia S; Lorenzi C; Pirovano A; Radaelli D; Locatelli C; Poletti S; Colombo C; Smeraldi E
J Affect Disord; 2012 Feb; 136(3):514-9. PubMed ID: 22119086
[TBL] [Abstract][Full Text] [Related]
14. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
[TBL] [Abstract][Full Text] [Related]
15. Temporal lobe grey matter volume in schizophrenia is associated with a genetic polymorphism influencing glycogen synthase kinase 3-β activity.
Benedetti F; Poletti S; Radaelli D; Bernasconi A; Cavallaro R; Falini A; Lorenzi C; Pirovano A; Dallaspezia S; Locatelli C; Scotti G; Smeraldi E
Genes Brain Behav; 2010 Jun; 9(4):365-71. PubMed ID: 20113358
[TBL] [Abstract][Full Text] [Related]
16. Region-specific dysregulation of glycogen synthase kinase-3β and β-catenin in the postmortem brains of subjects with bipolar disorder and schizophrenia.
Pandey GN; Rizavi HS; Tripathi M; Ren X
Bipolar Disord; 2015 Mar; 17(2):160-71. PubMed ID: 25041379
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the Association between Lithium Treatment and GSK3β Polymorphism in Bipolar Disorder Patients].
Altınbaş K; Yeşilbaş D; İnce B; Cansız A; Sılan F; Özdemir Ö; Gülöksüz S
Turk Psikiyatri Derg; 2018; 29(2):73-78. PubMed ID: 30215834
[TBL] [Abstract][Full Text] [Related]
18. A specific group of patients with diagnostic conversion from depression to bipolar disorder and finally to dementia as a mental GSK-3 disease: A hypothesis.
Terao T; Ishii N; Hirakawa H
Bipolar Disord; 2020 Jun; 22(4):356-359. PubMed ID: 31742842
[TBL] [Abstract][Full Text] [Related]
19. Lithium prevents grey matter atrophy in patients with bipolar disorder: an international multicenter study.
Hozer F; Sarrazin S; Laidi C; Favre P; Pauling M; Cannon D; McDonald C; Emsell L; Mangin JF; Duchesnay E; Bellani M; Brambilla P; Wessa M; Linke J; Polosan M; Versace A; Phillips ML; Delavest M; Bellivier F; Hamdani N; d'Albis MA; Leboyer M; Houenou J
Psychol Med; 2021 May; 51(7):1201-1210. PubMed ID: 31983348
[TBL] [Abstract][Full Text] [Related]
20. Association study of the INPP1, 5HTT, BDNF, AP-2beta and GSK-3beta GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder.
Michelon L; Meira-Lima I; Cordeiro Q; Miguita K; Breen G; Collier D; Vallada H
Neurosci Lett; 2006 Aug; 403(3):288-93. PubMed ID: 16787706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
